KURA
Kura Oncology
$9.62
+$0.01 (+0.1%)Oct 26, 2026
Key metrics
The numbers that frame KURA today
- Market cap
- $855.80M
- Gross margin
- 99.3%
- EV / Sales
- 10.5
- ROIC
- -62%
- Div yield
- 0%
- Debt / equity
- 0.5
- 52wk Low
- $7.36
- 52wk High
- $13.90
Growth
Revenue and earnings trend for KURA
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about KURA
Is Kura Oncology a good buy?
Hold. Kura Oncology has excellent momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Kura Oncology is selling at a very high price.
What is the market capitalization of KURA?
Kura Oncology's market capitalization is $855.80M.
What is the 52-week high for KURA stock?
The 52-week high for Kura Oncology is $13.90. The current close of $9.62 is 30.8% below that high.
What is the 52-week low for KURA stock?
The 52-week low for Kura Oncology is $7.36. The current close of $9.62 is 30.8% above that low.
Does KURA stock pay dividends?
Kura Oncology does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for KURA?
Kura Oncology's Debt / Equity ratio is 0.51.